
|
Yukon
Territory
|
###-##-####
|
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer Identification No.)
|
|
|
incorporation
or organization)
|
|
Page
Number
|
||
|
PART
I.
|
||
|
Item
1.
|
||
|
Item
2.
|
||
|
Item
3.
|
||
|
Item
4.
|
||
|
PART
II.
|
||
|
Item
1.
|
||
|
Item
1A.
|
||
|
Item
6.
|
||
|
PART I.
|
|
ITEM
1.
|
CONSOLIDATED
FINANCIAL STATEMENTS
|
|
December
31, 2009
|
March
31, 2009
|
|||||||
|
ASSETS
|
||||||||
|
Current
Assets
|
||||||||
|
Cash
and cash equivalents
|
$ | 3,979,487 | $ | 6,138,530 | ||||
|
Funds
held in trust
|
718,093 | - | ||||||
|
Funds
held for merchants (Note 8)
|
4,266,636 | 10,746,731 | ||||||
|
Restricted
cash
|
175,000 | 175,000 | ||||||
|
Accounts
receivable, less allowances of $30,474 and $31,785,
respectively
|
756,967 | 801,087 | ||||||
|
Corporate
taxes receivable
|
582,863 | - | ||||||
|
Prepaid
expenses
|
301,257 | 295,702 | ||||||
|
Current
portion of future income tax assets
|
1,852,894 | 838,575 | ||||||
|
Total
current assets
|
12,633,197 | 18,995,625 | ||||||
|
Property
and equipment, net
|
235,978 | 227,324 | ||||||
|
Patents,
net
|
497,160 | 622,730 | ||||||
|
Restricted
cash
|
250,048 | 125,030 | ||||||
|
Future
income tax assets
|
3,370,685 | 4,429,578 | ||||||
|
Other
assets
|
20,362 | 19,020 | ||||||
|
Goodwill
|
17,874,202 | 17,874,202 | ||||||
|
Other
intangible assets, net
|
4,834,125 | 5,205,487 | ||||||
|
TOTAL
ASSETS
|
$ | 39,715,757 | $ | 47,498,996 | ||||
|
LIABILITIES
|
||||||||
|
Current
Liabilities
|
||||||||
|
Accounts
payable
|
$ | 748,215 | $ | 756,845 | ||||
|
Accrued
liabilities
|
765,071 | 814,094 | ||||||
|
Corporate
taxes payable
|
- | 283,794 | ||||||
|
Funds
due to merchants (Note 8)
|
4,266,636 | 10,746,731 | ||||||
|
Obligations
under capital lease
|
30,043 | 170,243 | ||||||
|
Promissory
notes
|
- | 2,100,920 | ||||||
|
Current
portion of deferred revenue
|
1,312,366 | 1,361,046 | ||||||
|
Total
current liabilities
|
7,122,331 | 16,233,673 | ||||||
|
Deferred
revenue
|
2,466,031 | 3,330,630 | ||||||
|
TOTAL
LIABILITIES
|
9,588,362 | 19,564,303 | ||||||
|
Commitments
and Contingencies (Note 11)
|
||||||||
|
SHAREHOLDERS'
EQUITY
|
||||||||
|
Capital
Stock
|
||||||||
|
Class
A, preferred stock, $1.00 CDN par value, 150,000,000 shares authorized,
issuable in series, none issued or outstanding
|
- | - | ||||||
|
Class
B, preferred stock, $1.00 CDN par value, 150,000,000 shares authorized,
issuable in series, none issued or outstanding
|
- | - | ||||||
|
Common
shares, no par value, 100,000,000 shares authorized, 27,116,408 and
27,116,408 issued and outstanding, respectively
|
50,039,568 | 50,039,568 | ||||||
|
Contributed
surplus
|
7,663,735 | 6,732,059 | ||||||
|
Deficit
|
(27,680,447 | ) | (28,751,456 | ) | ||||
|
Accumulated
other comprehensive income (loss)
|
104,539 | (85,478 | ) | |||||
|
Total
shareholders' equity
|
30,127,395 | 27,934,693 | ||||||
|
TOTAL
LIABILITIES AND SHAREHOLDERS' EQUITY
|
$ | 39,715,757 | $ | 47,498,996 | ||||
|
Three
Months Ended
December
31
|
Nine
months Ended
December
31
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
REVENUE
|
$ | 4, 742,568 | $ | 3,037,241 | $ | 11,229,773 | $ | 9,301,687 | ||||||||
|
COST
OF REVENUE (includes stock-based compensation (“s.b.c.”) expense of
$37,464 for three months ended December 31, 2009 (three months ended
December 31, 2008 - $37,464) and $111,579 for nine months ended December
31, 2009 (nine months ended December 31, 2008 - $113,066))
|
2,329,810 | 1,560,708 | 5,670,576 | 4,580,407 | ||||||||||||
|
GROSS
PROFIT (excludes amortization and depreciation expense)
|
2,412,758 | 1,476,533 | 5,559,197 | 4,721,280 | ||||||||||||
|
OPERATING
EXPENSES
|
||||||||||||||||
|
General
and administrative (includes s.b.c. expense of $243,028 for three months
ended December 31, 2009 (three months ended December 31, 2008 - $274,297)
and $781,386 for nine months ended December 31, 2009 (nine months ended
December 31, 2008- $871,255))
|
1,059,165 | 962,623 | 3,083,629 | 3,209,063 | ||||||||||||
|
Sales
and marketing (includes s.b.c. expense of $765 for three months ended
December 31, 2009 (three months ended December 31, 2008 - $765) and $2,277
for nine months ended December 31, 2009 (nine months ended December 31,
2008 - $2,285))
|
103,481 | 77,149 | 296,084 | 237,715 | ||||||||||||
|
Product
development and enhancement (includes s.b.c. expense of $12,233 for three
months ended December 31, 2009 (three months ended December 31, 2008 -
$12,233) and $36,434 for nine months ended December 31, 2009 (nine months
ended December 31, 2008 - $36,567))
|
122,759 | 58,279 | 342,585 | 197,589 | ||||||||||||
|
Amortization
and depreciation
|
200,346 | 197,102 | 596,930 | 589,654 | ||||||||||||
|
(Gain)
on sale of assets
|
- | - | (3,830 | ) | (864 | ) | ||||||||||
|
INCOME
BEFORE OTHER INCOME (EXPENSES) AND INCOME TAXES
|
927,007 | 181,380 | 1,243,799 | 488,123 | ||||||||||||
|
|
||||||||||||||||
|
Foreign exchange
gain
|
10,928 | 281,682 | 135,296 | 380,650 | ||||||||||||
|
Other income
(expenses)
|
- | 10,833 | (50,641 | ) | 29,808 | |||||||||||
|
Interest income
|
4,285 | 58,750 | 20,549 | 202,719 | ||||||||||||
|
Interest
expense
|
(846 | ) | (45,269 | ) | (47,676 | ) | (204,154 | ) | ||||||||
|
INCOME BEFORE
INCOME TAXES
|
941,374 | 487,376 | 1,301,327 | 897,146 | ||||||||||||
|
Income
tax expense (recovery) (Note 10)
|
||||||||||||||||
|
Current
|
(324,275 | ) | 206,074 | (323,647 | ) | 597,018 | ||||||||||
|
Future
|
650,119 | - | 553,965 | - | ||||||||||||
| 325,844 | 206,074 | 230,318 | 597,018 | |||||||||||||
|
NET
INCOME
|
615,530 | 281,302 | 1,071,009 | 300,128 | ||||||||||||
|
DEFICIT,
beginning of period
|
(28,295,977 | ) | (34,187,796 | ) | (28,751,456 | ) | (34,206,622 | ) | ||||||||
|
DEFICIT,
end of period
|
$ | (27,680,447 | ) | $ | (33,906,494 | ) | $ | (27,680,447 | ) | $ | (33,906,494 | ) | ||||
|
EARNINGS PER
SHARE, basic and diluted
|
$ | 0.02 | $ | 0.01 | $ | 0.04 | $ | 0.01 | ||||||||
|
WEIGHTED
AVERAGE SHARES OUTSTANDING
|
||||||||||||||||
|
Basic
|
27,116,408 | 27,116,408 | 27,116,408 | 26,741,795 | ||||||||||||
|
Diluted
|
27,252,792 | 27,116,408 | 27,150,430 | 26,741,795 | ||||||||||||
|
Three
Months Ended
December
31
|
Nine
months Ended
December
31
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
Net
income
|
$ | 615,530 | $ | 281,302 | $ | 1,071,009 | $ | 300,128 | ||||||||
|
Unrealized
foreign exchange gain on translation of self- sustaining
operations
|
23,174 | 782 | 190,017 | 14,332 | ||||||||||||
|
Comprehensive
income
|
$ | 638,704 | $ | 282,084 | $ | 1,261,026 | $ | 314,460 | ||||||||
|
Three
Months Ended
December
31
|
Nine
months Ended
December
31
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
Operating
Activities:
|
||||||||||||||||
|
Net
income
|
$ | 615,530 | $ | 281,302 | $ | 1,071,009 | $ | 300,128 | ||||||||
|
Adjustments
to reconcile net income to net cash provided by (used in) operating
activities
|
||||||||||||||||
|
Provision for losses on
accounts receivable
|
- | - | 5,705 | - | ||||||||||||
|
Amortization and
depreciation
|
200,346 | 197,102 | 596,930 | 589,654 | ||||||||||||
|
Gain on sale
of assets
|
- | - | (3,830 | ) | (864 | ) | ||||||||||
|
Stock-based
compensation
|
293,490 | 324,759 | 931,676 | 1,023,173 | ||||||||||||
|
Future income
taxes
|
650,119 | - | 553,965 | - | ||||||||||||
|
Foreign exchange (gain)
loss
|
(52,253 | ) | (302,231 | ) | (331,716 | ) | (298,891 | ) | ||||||||
|
Changes
in non-cash operating working capital
|
||||||||||||||||
|
Funds
held in trust
|
(718,093 | ) | - | (718,093 | ) | - | ||||||||||
|
Restricted
cash
|
(100,000 | ) | - | (100,000 | ) | 125,000 | ||||||||||
|
Accounts
receivable
|
(145,436 | ) | 1,217 | 71,714 | 136,826 | |||||||||||
|
Corporate
taxes receivable
|
(432,147 | ) | - | (582,863 | ) | - | ||||||||||
|
Prepaid
expenses
|
152,228 | (21,094 | ) | 3,202 | (31,127 | ) | ||||||||||
|
Accounts
payable and accrued liabilities
|
(4,503 | ) | 31,649 | (70,949 | ) | (801,937 | ) | |||||||||
|
Corporate
taxes payable
|
(6,991 | ) | 55,872 | (327,673 | ) | (517,121 | ) | |||||||||
|
Deferred
revenue
|
(377,545 | ) | (348,875 | ) | (923,947 | ) | (1,108,374 | ) | ||||||||
|
Net
cash provided by (used in) operating activities
|
74,745 | 219,701 | 175,130 | (583,533 | ) | |||||||||||
|
Investing
Activities:
|
||||||||||||||||
|
Acquisition
of property and equipment
|
(75,497 | ) | (16,744 | ) | (90,017 | ) | (106,147 | ) | ||||||||
|
Proceeds
from disposal of property and equipment
|
- | - | 3,830 | 5,500 | ||||||||||||
|
Development
of patents
|
- | - | - | (1,652 | ) | |||||||||||
|
Net
cash used in investing activities
|
(75,497 | ) | (16,744 | ) | (86,187 | ) | (102,299 | ) | ||||||||
|
Financing
Activities:
|
||||||||||||||||
|
Payments
on capital leases
|
(39,552 | ) | (48,939 | ) | (140,882 | ) | (142,335 | ) | ||||||||
|
Payment
on promissory notes
|
- | - | (2,321,460 | ) | (2,843,974 | ) | ||||||||||
|
Share
capital financing costs
|
- | - | - | (3,537 | ) | |||||||||||
|
Net
cash used in financing activities
|
(39,552 | ) | (48,939 | ) | (2,462,342 | ) | (2,989,846 | ) | ||||||||
|
Effects
of foreign exchange rate changes on cash and cash
equivalents
|
16,457 | (54,565 | ) | 214,356 | (39,236 | ) | ||||||||||
|
(DECREASE)
INCREASE IN CASH AND CASH EQUIVALENTS
|
(23,847 | ) | 99,453 | (2,159,043 | ) | (3,714,914 | ) | |||||||||
|
Cash
and cash equivalents, beginning of period
|
4,003,334 | 5,935,401 | 6,138,530 | 9,749,768 | ||||||||||||
|
Cash
and cash equivalents, end of period
|
$ | 3,979,487 | $ | 6,034,854 | $ | 3,979,487 | $ | 6,034,854 | ||||||||
|
Supplemental
disclosure of cash flow information
|
||||||||||||||||
|
Interest
paid
|
$ | 846 | $ | 4,581 | $ | 47,939 | $ | 411,171 | ||||||||
|
Taxes
paid
|
- | $ | 201,476 | $ | 435,138 | $ | 1,173,893 | |||||||||
|
Non-cash
investing and financing transactions not included in cash
flows:
|
||||||||||||||||
|
Issuance
of common shares pursuant to earn-out provision
|
- | - | - | $ | 1,971,125 | |||||||||||
|
1.
|
Basis
of Presentation
|
|
2.
|
Significant
Accounting Policies
|
|
2.
|
Significant
Accounting Policies (continued)
|
|
·
|
Licenses
– licenses are issued for the use of existing
patents;
|
|
·
|
Release
from litigation – the subsidiary of the Corporation releases the licensees
from any claims or causes of action for patent infringement as of the
effective date of the underlying
agreement;
|
|
·
|
Covenant-not-to-sue
provision – the subsidiary of the Corporation agrees to a
covenant-not-to-sue provision for infringement of any patents for a
specified period commencing on the effective date of the underlying
agreement.
|
|
3.
|
Change
in Accounting Policy
|
|
4.
|
Recent
accounting pronouncements
|
|
4.
|
Recent
accounting pronouncements
(continued)
|
|
·
|
The
amendment clarifies that if an entity reclassifies a financial asset out
of the held-for-trading category, it must assess whether the financial
asset contains an embedded derivative that is required to be separated
from the host contract. This assessment is made on the basis of
circumstances that existed on the later date of specified dates provided
in the amendment.
|
|
·
|
If
an embedded derivative cannot be measured reliably, the entity is
prohibited from reclassifying the asset from
held-for-trading.
|
|
·
|
When
a financial asset or a group of similar financial assets (other than the
loans and receivables category) has been written down as a result of an
impairment loss, interest income is recognized thereafter using the rate
of interest used in the measurement of the impairment
loss.
|
|
·
|
An
embedded call, put, surrender or prepayment option is closely related to
the host debt instrument when its exercise price reimburses the lender for
an amount up to the approximate present value of the lost interest.
Calculation guidance to determine the lost interest is provided in the
amendment.
|
|
5.
|
Foreign
currency translation
|
|
6.
|
Economic
dependence
|
|
7.
|
Financial
instruments
|
|
|
(a)
|
The
Corporation classifies its cash and cash equivalents, funds held in trust,
funds held for merchants and restricted cash as held-for-trading. Accounts
receivable are classified as loans and receivables. Accounts payable and
certain accrued liabilities, funds due to merchants, and promissory notes
are classified as other liabilities, all of which are measured at
amortized cost (using the effective interest rate
method).
|
|
December
31, 2009
|
March
31, 2009
|
|||||||||||||||
|
Carrying
Value
|
Fair
Value
|
Carrying
Value
|
Fair
Value
|
|||||||||||||
|
Held-for-Trading
|
$ | 9,389,264 | $ | 9,389,264 | $ | 17,185,291 | $ | 17,185,291 | ||||||||
|
Loans
and receivables
|
756,967 | 756,967 | 801,087 | 801,087 | ||||||||||||
|
Held-to-maturity
|
- | - | - | - | ||||||||||||
|
Available-for-sale
|
- | - | - | - | ||||||||||||
|
Other
liabilities
|
5,779,922 | 5,779,922 | 14,418,590 | 14,418,590 | ||||||||||||
|
7.
|
Financial
Instruments (continued)
|
|
|
(b)
|
Funds
held in trust
|
|
|
During
the three and nine month period ended December 31, 2009, $718,093 in cash
was held in trust for a subsidiary of the Corporation by the Corporation’s
legal firm. This cash was received pursuant to a Settlement and
License Agreement entered into by a subsidiary of the Corporation with one
of the defendants in the patent infringement lawsuit originally filed on
November 19, 2008 in the U.S. District Court for the Eastern District of
Texas against nineteen defendants in the United States alleging that
the defendants infringe U.S. Patent No.
RE40220. Subsequent to the three and nine months ended
December 31, 2009, the cash was released from trust to the subsidiary of
the Corporation.
|
|
|
(c)
|
Restricted
cash
|
|
|
(d)
|
Market
Risk
|
|
December
31, 2009
|
March
31, 2009
|
|||||||
|
Cash
and restricted cash
|
$ | 38,121 | $ | 1,172,539 | ||||
|
Accounts
receivable
|
- | 50,476 | ||||||
|
Accounts
payable
|
89,799 | 132,570 | ||||||
|
Accrued
liabilities
|
282,518 | 333,360 | ||||||
|
Promissory
notes
|
- | 2,100,920 | ||||||